These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6053979)

  • 1. Effect of glucagon in intravenous glucose tolerance.
    Turner DA; Audhya TK; Cramp DG; Holdsworth CD; McIntyre N
    Br Med J; 1967 Oct; 4(5572):145-6. PubMed ID: 6053979
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin, free fatty acids, and glucose response to intravenous glucagon following myocardial infarction.
    Gupta PR; Sinha MK; Dash RJ; Wahi PL; Rastogi GK
    Circulation; 1974 Feb; 49(2):357-60. PubMed ID: 4589699
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of the intestinal polypeptides, IRP, GIP, VIP and motilin on insulin release in the rat.
    Turner DS; Etheridge L; Marks V; Brown JC; Mutt V
    Diabetologia; 1974 Oct; 10(5):459-63. PubMed ID: 4452430
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin response to glucagon. The opposing effects of diabetes and obesity.
    Crockford PM; Hazzard WR; Williams RH
    Diabetes; 1969 Apr; 18(4):216-24. PubMed ID: 5776458
    [No Abstract]   [Full Text] [Related]  

  • 5. Diminished response to glucagon in the dextros-primed neonate.
    Pildes RS; Ramamurthy RS; Patel DA
    Am J Dis Child; 1974 Mar; 127(3):333-5. PubMed ID: 4814880
    [No Abstract]   [Full Text] [Related]  

  • 6. The behaviour of insulinaemia in patients ith liver cirrhosis after intravenous administration of glucose, tolbutamide and glucagon.
    Kasperska T; Lawecki J; Rogala H; Czyzyk A
    Diabetologia; 1971 Oct; 7(5):391-4. PubMed ID: 5134260
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
    Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
    Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma insulin disturbances in primary hyperparathyroidism.
    Kim H; Kalkhoff RK; Costrini NV; Cerletty JM; Jacobson M
    J Clin Invest; 1971 Dec; 50(12):2596-605. PubMed ID: 5129311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of oral glucose loading on the insulin response to i.v. glucagon in children and adolescents.
    Josefsberg Z; Flatau E; Doron M; Laron Z
    Metabolism; 1976 Mar; 25(3):277-80. PubMed ID: 1250162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemic and insulogenic effects of intravenous glucagon at different blood glucose levels.
    Garcia MJ; Czerwinski C; De Santis R; Lan VV; Ramey E; Penhos JC
    Proc Soc Exp Biol Med; 1973 Jul; 143(3):707-10. PubMed ID: 4719456
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of hGH deficiency on the insulin response to glucagon after oral glucose loading.
    Laron Z; Mimouni M; Josefsberg Z; Zadik Z; Doron M
    Diabetologia; 1977 Sep; 13(5):447-50. PubMed ID: 908467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice.
    Song G; Pacini G; Ahrén B; D'Argenio DZ
    Peptides; 2017 Feb; 88():74-79. PubMed ID: 28012858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic cholinergic modulation of insulin response to an intravenous glucose tolerance test in normal man.
    Coiro V; Chiodera P; Volpi R; d'Amato L; Camellini L; Rossi G; Pignatti D; Butturini U
    J Endocrinol Invest; 1986 Feb; 9(1):27-30. PubMed ID: 3517121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood levels of insulin, glucagon and gastrin following intravenous and oral glucose administration in children with simple obesity.
    Sztefko K; Rybakowa M; Szafran Z; Sucharski P; Sołtysik-Wilk E; Jaworska W
    Endokrynol Pol; 1988; 39(5):253-61. PubMed ID: 3076563
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of glucagon on insulin secretion. 1. A clinical study].
    Kuroda K
    Nihon Naibunpi Gakkai Zasshi; 1973 Dec; 49(12):1407-17. PubMed ID: 4798030
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between insulin response during the intravenous glucose tolerance test, rate of fractional glucose removal and the degree of insulin resistance in normal adults.
    Reaven GM; Olefsky JM
    Diabetes; 1974 May; 23(5):454-9. PubMed ID: 4830181
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin secretion in protein-calorie malnutrition. I. Quantitative abnormalities and response to treatment.
    Becker DJ; Pimstone BL; Hansen JD; Hendricks S
    Diabetes; 1971 Aug; 20(8):542-51. PubMed ID: 5565001
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma glucagon in obesity. Response to arginine, glucose and protein administration.
    Kalkhoff RK; Gossain VV; Matute ML
    N Engl J Med; 1973 Aug; 289(9):465-7. PubMed ID: 4587235
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormonal responses to intravenous and oral glucose tolerance testing in a patient with a gastrinoma and a gastrojejunostomy.
    Massaro RP
    Gastroenterology; 1974 May; 66(5):1058-62. PubMed ID: 4363772
    [No Abstract]   [Full Text] [Related]  

  • 20. Exhaustion of blood glucose response and enhancement of insulin response after repeated glucagon injections in type-2 diabetes: potentiation by progressive hyperglycemia.
    Castillo MJ; Scheen AJ; Paolisso G; Lefebvre PJ
    Ann Endocrinol (Paris); 1996; 57(5):395-402. PubMed ID: 8991103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.